泰凌医药拟就债务资本化配发合共4.1亿股

格隆汇
28 Nov 2024

格隆汇11月28日丨泰凌医药(01011.HK)公告,于2024年11月28日,公司与认购人A Golden Base Investment Limited及认购人B 杨溢先生订立认购协议,据此,公司已有条件同意(i)向认购人A配发及发行,且认购人A已有条件同意认购2.64亿股新股份,认购价为每股认购股份0.33港元,总代价为8700万港元,将通过抵销贷款协议A项下股东贷款的未偿还本金额及应计利息...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10